REQUEST A DEMO
Total
USD $0.00
Search more companies

Guangzhou Wondfo Biotech Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Electromedical and Electrotherapeutic Apparatus Manufacturing
Full name: Guangzhou Wondfo Biotech Co.,Ltd Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Guangzhou Wondfo Biotech Co., Ltd is a company located in Guangzhou, China. The company specializes in the research, production, and sales of rapid diagnostic products in the field of biopharmaceutical in vitro diagnostics, including reagents and instruments. It is the first domestic in vitro diagnostic reagent enterprise to pass the on-site assessment of "zero defects" by the US Food and Drug Administration. The company has been recognized as a "national high-tech enterprise," "demonstration base for the industrialization of biotechnology high-tech by the National Development and Reform Commission," and a "key enterprise in the export of electromechanical and high-tech products" by the Ministry of Commerce. It has obtained international authoritative quality management system certifications such as CE, ISO9001, and ISO13485. The company has established a production line for colloidal gold rapid diagnostic reagents with international advanced level, covering an area of 2000 square meters of clean production workshops, with an annual production capacity of 160 million people. In 2011, the National Development and Reform Commission approved the establishment of the "National Local Joint Self-Inspection Rapid Diagnostic Engineering Laboratory" in the company. The company's research and development products cover more than 70 varieties in 8 major series, including infectious diseases, pregnancy, cardiovascular diseases, drug testing, tumors, autoimmune diseases, food safety testing, and integrated instrument reagents. The company's sales volume has been increasing year by year, making it one of the leading medical device manufacturers in China and a leader in the POCT industry.

Headquarters
8 Lizhishan Road Sci. Mega-Center Luogang District Guangzhou Guangdong
Guangzhou; Guangdong; Postal Code: 510641

Contact Details: Purchase the Guangzhou Wondfo Biotech Co.,Ltd report to view the information.

Website: http://www.wondfo.com.cn

Basic Information
Total Employees:
Purchase the Guangzhou Wondfo Biotech Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Guangzhou Wondfo Biotech Co.,Ltd report to view the information.
Registered Capital:
Purchase the Guangzhou Wondfo Biotech Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Guangzhou Wondfo Biotech Co.,Ltd report to view the information.
Incorporation Date:
November 13, 1992
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
20.73%
Purchase this report to view the information.
10.51%
Purchase this report to view the information.
10.42%
Purchase this report to view the information.
1.79%
Purchase this report to view the information.
1.79%
Subsidiaries
Guangdong Wanfu Intelligent Manufacturing Technology Co., Ltd.
100%
Guangzhou Wanxin Industry Development Co., Ltd.
100%
Guangzhou Wei''an Biological Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Guangzhou Wondfo Biotech Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
34.27%
Total operating revenue
32.07%
Operating profit (EBIT)
8.63%
Net Profit (Loss) for the Period
19.49%
Total assets
-1.33%
Total equity
0.75%
Operating Profit Margin (ROS)
-4.98%
Net Profit Margin
-2.46%
Return on Equity (ROE)
1.31%
Debt to Equity Ratio
0.68%
Quick Ratio
1.79%
Cash Ratio
-0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?